ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,753.70
0.35%
S&P ASX All Technology
3,050.50
0.56%
Brent Oil
81.685
-1.05%
US Dollar vs AUD
1.50589
-0.25%
Bitcoin
64,405.25
4.64%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) News

INAB IN8bio Inc

1.03
-0.01 (-0.96%)
Last Updated: 00:17:34
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
IN8bio Inc INAB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.01 -0.96% 1.03 00:17:34
Open Price Low Price High Price Close Price Previous Close
1.04 0.99 1.04 1.04
more quote information »

Recent News

Date Time Source Heading
15/5/202400:00GLOBEIN8bio Announces Upcoming Presentation at 2024 European..
13/5/202422:00GLOBEIN8bio Demonstrates Robust and Reproducible Gamma-Delta T..
10/5/202406:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202406:04EDGAR2Form 8-K - Current report
10/5/202406:00GLOBEIN8bio Reports First Quarter 2024 Financial Results and..
08/5/202406:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/4/202420:05GLOBEIN8bio Doses First Patient in Phase 2 Clinical Trial of..
24/4/202422:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
17/4/202406:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
10/4/202406:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
15/3/202407:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
06/3/202408:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
27/2/202400:00BWIN8bio to Present at Upcoming Investor Conferences
15/2/202400:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
09/2/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202408:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202409:16EDGAR2Form S-3 - Registration statement under Securities Act of..
05/1/202400:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
16/12/202308:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/12/202300:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202309:15EDGAR2Form 8-K - Current report
12/12/202308:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
12/12/202301:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
12/12/202300:56EDGAR2Form 8-K - Current report
09/12/202308:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202308:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/12/202308:15EDGAR2Form 8-K - Current report
08/12/202300:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
06/12/202300:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
21/11/202301:04EDGAR2Form 8-K - Current report
20/11/202323:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
10/11/202323:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
10/11/202308:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:03EDGAR2Form 8-K - Current report
10/11/202308:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..

Your Recent History

NASDAQ
INAB
IN8bio
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved